Background: Mitiglinide, one of the meglitinides, is expected to prevent postprandial hyperglycemia of type
There are significant reductions of HbA1c in both groups (**; P <0.001); B, The graph shows the difference of HbA1c changes between two groups for 12 weeks by independent t-test. There is no significant difference of HbA1c between two groups (P = 0.57). B A Fig. 3 . The % of patients according to the HbA1c reductions after 12 week treatment. A, △ HbA1c ≥ 1%; B, △ HbA1c ≥ 0.5%. There are no significant differences of % of patients between two groups by independent t-test, respectively.
는 없었다 (Table 1) There are significant reductions of FPG in both groups (*; P <0.05, ** P <0.001); B, The graph shows the difference of FPG changes between two groups for 12 weeks by independent t-test. There is no significant difference of HbA1c between two groups (P = 0.218).
의 HbA1c가 1% 이상 개선된 환자의 비율은 각각 34.0%,
34.8%로 두 군 간에서 통계적으로 유의한 차이는 없었다
(P = 0.940) (Fig. 3A) . 또한 0.5% 이상 개선된 환자의 비 율도 각각 63.8%, 56.5%로 통계적으로 유의한 차이가 없었 다 (P = 0.470) (Fig. 3B) . 참 고 문 헌 
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